Table 1 Patient descriptive characteristics
Patients’ physical exploration | ||
|---|---|---|
N = 98 | Basal visit | Final visit |
Weight (kg) | 82.2 (16.0) | 81.8 (15.9) |
Body mass index (BMI) (kg/m2) | 30.0 (5.2) | 29.8 (5.2) |
Waist perimeter (WP) (cm) | 101.3 (13.1) | 102.2 (14.8) |
Abdominal obesity | ||
According to IDF (WP > 80 cm women and > 90 cm men) | 89 (90.8%) | 88 (89.8%) |
According to GLESMO (WP > 88 cm women and > 94 cm men) | 76 (77.6%) | 78 (79.6%) |
According to NCEP-ATP III (WP > 88 cm women and > 102 cm men) | 62 (63.3%) | 62 (63.3%) |
Fasting glycaemia (mg/dL) | 107.7 (16.8) | |
HbA1c (%) | 7.9 (0.6) | |
HbA1c (mmol/mol) | 63 (6) | |
Oral antidiabetic drugs used | ||
Basal insulin dose (U/day) | 31.6 (17) | 31.6 (16.9) |
Any OAD | 87 (88.8%) | 89 (90.8%) |
Metformin | 80 (81.6%) | 81 (82.7%) |
Sulfonylureas | 31 (31.6%) | 31 (31.6%) |
DPP-4 inhibitor | 30 (30.6%) | 31 (31.6%) |